Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Doximity, Inc. (DOCS)

NYSE:DOCS

DOCS

Doximity

RESEARCH TOOLSreports

Doximity (DOCS) Stock News & Sentiment

Compare

980 Followers

Down Over 30% This Year: Analysts Double Down on These 3 Beaten-Down Stocks

Premium

Stock Analysis & Ideas

Down Over 30% This Year: Analysts Double Down on These 3 Beaten-Down Stocks

12d ago

TRI

Doximity: Network Effects, Normalizing Pharma Budgets, and Undemanding Valuation Create an Attractive Buy Opportunity

Premium

Ratings

Doximity: Network Effects, Normalizing Pharma Budgets, and Undemanding Valuation Create an Attractive Buy Opportunity

23d ago

DOCS

Premium

Company Announcements

Doximity (DOCS) Earnings Call: AI, Buybacks and Growth

24d ago

DOCS

Doximity: Rebounding Pharma Momentum, Emerging AI Upside, and Attractive Valuation Support Renewed Growth Buy Thesis

Premium

Ratings

Doximity: Rebounding Pharma Momentum, Emerging AI Upside, and Attractive Valuation Support Renewed Growth Buy Thesis

25d ago

DOCS

Buy Rating on Doximity: Near‑Term Timing Headwinds Create an Attractive Entry Point Amid Durable Growth and Margin Strength

Premium

Ratings

Buy Rating on Doximity: Near‑Term Timing Headwinds Create an Attractive Entry Point Amid Durable Growth and Margin Strength

26d ago

DOCS

Doximity: Buy Rating Reaffirmed as Attractive Valuation and Emerging AI Growth Offset Near‑Term Macro Headwinds

Premium

Ratings

Doximity: Buy Rating Reaffirmed as Attractive Valuation and Emerging AI Growth Offset Near‑Term Macro Headwinds

26d ago

DOCS

Doximity: Resilient Fundamentals and AI-Driven Growth Support Buy Rating Despite Temporary Pharma Budget Delays

Premium

Ratings

Doximity: Resilient Fundamentals and AI-Driven Growth Support Buy Rating Despite Temporary Pharma Budget Delays

26d ago

DOCS

More DOCS News >

DOCS News on the Web

2026-02-20

Doximity price target lowered to $33 from $40 at JPMorgan

TipRanks News

Neutral

2026-02-20

Doximity price target raised to $42 from $40 at Piper Sandler

TipRanks News

Bullish

2026-02-19

Down Over 30% This Year: Analysts Double Down on These 3 Beaten-Down Stocks

TipRanks News

Bullish

2026-02-13

PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up

Zacks

Bullish

2026-02-13

Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release?

Zacks

Neutral

2026-02-12

AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline

Zacks

Bullish

2026-02-12

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Humana (HUM)

TipRanks News

Bullish

2026-02-12

QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down

Zacks

Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DOCS’s Media Buzz Sentiment?

Currently, no data Available

What is DOCS’s weekly average amount of articles?

Currently, no data Available

What is DOCS’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

XERSXeris Pharmaceuticals

KIDSOrthoPediatrics

PRVAPrivia Health Group

NGNENeurogene

CONConcentra Group Holdings Parent, Inc.

Showing the stocks with the most bullish news sentiment over the past week